메뉴 건너뛰기




Volumn 106, Issue 2, 2002, Pages 149-156

Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: Platelet responses to human anti-heparin-platelet factor 4 antibodies

Author keywords

Anti heparin platelet factor 4 antibodies; Antibody subtypes isotypes; GP IIb IIIa receptor antagonists; HIT syndrome; Platelet activation

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4; TIROFIBAN;

EID: 0037089054     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00081-6     Document Type: Article
Times cited : (10)

References (27)
  • 1
    • 0026844620 scopus 로고
    • Heparin-induced thrombocytopenia
    • Chong B.H. Heparin-induced thrombocytopenia. Aust. N. Z. J. Med. 22:1992;145-152.
    • (1992) Aust. N. Z. J. Med. , vol.22 , pp. 145-152
    • Chong, B.H.1
  • 2
    • 0034235911 scopus 로고    scopus 로고
    • Heparin-induced thrombocytopenia: New evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation
    • Newman P.M., Chong B.H. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 96:2000;182-187.
    • (2000) Blood , vol.96 , pp. 182-187
    • Newman, P.M.1    Chong, B.H.2
  • 4
    • 0029086769 scopus 로고
    • Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia
    • Greinacher A., Alban S., Dummel V., Franz G., Mueller-Eckhardt C. Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia. Thromb. Haemost. 74:1995;886-892.
    • (1995) Thromb. Haemost. , vol.74 , pp. 886-892
    • Greinacher, A.1    Alban, S.2    Dummel, V.3    Franz, G.4    Mueller-Eckhardt, C.5
  • 6
    • 0032747473 scopus 로고
    • Functional heterogeneity of anti-heparin platelet factor 4 antibodies: Implications in the pathogenesis of the HIT syndrome. Clin
    • Ahmad S., Walenga J.M., Jeske W.P., Cella G., Fareed J. Functional heterogeneity of anti-heparin platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome. Clin. Appl. Thromb. Haemost. 5(Suppl. 1):1995;S32-S37.
    • (1995) Appl. Thromb. Haemost. , vol.5 , Issue.SUPPL. 1
    • Ahmad, S.1    Walenga, J.M.2    Jeske, W.P.3    Cella, G.4    Fareed, J.5
  • 7
    • 0030463618 scopus 로고    scopus 로고
    • A diagnostic test for heparin-induced thrombocytopenia: Detection of platelet microparticles using flow cytometry
    • Lee D.H., Warkentin T.E., Denomme G.A., Hayward C.P.M., Kelton J.G. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br. J. Haematol. 95:1996;724-731.
    • (1996) Br. J. Haematol. , vol.95 , pp. 724-731
    • Lee, D.H.1    Warkentin, T.E.2    Denomme, G.A.3    Hayward, C.P.M.4    Kelton, J.G.5
  • 9
    • 0032903688 scopus 로고    scopus 로고
    • Laboratory tests for heparin-induced thrombocytopenia: A multicenter study
    • Walenga J.M., Jeske W.P., Wood J.J., Ahmad S., Lewis B.E., Bakhos M. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin. Hematol. 36(Suppl. 1):1999;22-28.
    • (1999) Semin. Hematol. , vol.36 , Issue.SUPPL. 1 , pp. 22-28
    • Walenga, J.M.1    Jeske, W.P.2    Wood, J.J.3    Ahmad, S.4    Lewis, B.E.5    Bakhos, M.6
  • 11
    • 0029417137 scopus 로고
    • On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia
    • Brandt J.T., Isenhart C.E., Osborne J.M., Ahmed A., Anderson C.L. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia. Thromb. Haemost. 74:1995;1564-1572.
    • (1995) Thromb. Haemost. , vol.74 , pp. 1564-1572
    • Brandt, J.T.1    Isenhart, C.E.2    Osborne, J.M.3    Ahmed, A.4    Anderson, C.L.5
  • 12
    • 0028871912 scopus 로고
    • Single amino acid mutation of Fcγ receptor is associated with the development of heparin induced thrombocytopenia
    • Burgess J.K., Lindeman R., Chesterman C.N., Berndt M.C. Single amino acid mutation of Fcγ receptor is associated with the development of heparin induced thrombocytopenia. Br. J. Haematol. 91:1995;761-766.
    • (1995) Br. J. Haematol. , vol.91 , pp. 761-766
    • Burgess, J.K.1    Lindeman, R.2    Chesterman, C.N.3    Berndt, M.C.4
  • 14
    • 0034306781 scopus 로고    scopus 로고
    • Human anti-heparin platelet factor 4 antibodies are capable of activating primate platelets: Towards the development of a HIT model in primates
    • Ahmad S., Jeske W.P., Walenga J.M., Aldabbagh A., Iqbal O., Fareed J. Human anti-heparin platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primates. Thromb. Res. 100:2000;47-54.
    • (2000) Thromb. Res. , vol.100 , pp. 47-54
    • Ahmad, S.1    Jeske, W.P.2    Walenga, J.M.3    Aldabbagh, A.4    Iqbal, O.5    Fareed, J.6
  • 15
    • 0031732776 scopus 로고    scopus 로고
    • In vitro efficacy of platelet glycoprotein IIb/IIIa antagonists in blocking platelet function in plasma of patients with HIT
    • Mak K., Kottke-Marchant K., Brooks L.M., Topol E.J. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonists in blocking platelet function in plasma of patients with HIT. Thromb. Haemost. 80:1998;989-993.
    • (1998) Thromb. Haemost. , vol.80 , pp. 989-993
    • Mak, K.1    Kottke-Marchant, K.2    Brooks, L.M.3    Topol, E.J.4
  • 17
    • 0032895104 scopus 로고    scopus 로고
    • Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT
    • Walenga J.M., Jeske W.P., Wallis D.E., Bahkos M., Lewis B.E., Leya F., Fareed J. Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT. Semin. Thromb. Hemost. 25(Suppl. 1):1999;177-183.
    • (1999) Semin. Thromb. Hemost. , vol.25 , Issue.SUPPL. 1 , pp. 177-183
    • Walenga, J.M.1    Jeske, W.P.2    Wallis, D.E.3    Bahkos, M.4    Lewis, B.E.5    Leya, F.6    Fareed, J.7
  • 18
    • 0031044144 scopus 로고    scopus 로고
    • The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies
    • Leim T.K., Teel R., Shukla S., Silver D. The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies. J. Vasc. Surg. 25:1997;124-130.
    • (1997) J. Vasc. Surg. , vol.25 , pp. 124-130
    • Leim, T.K.1    Teel, R.2    Shukla, S.3    Silver, D.4
  • 19
    • 0022640930 scopus 로고
    • A diagnostic test for heparin-induced thrombocytopenia
    • Sheridan D., Carter C., Kelton J.G. A diagnostic test for heparin-induced thrombocytopenia. Blood. 67:1986;27-30.
    • (1986) Blood , vol.67 , pp. 27-30
    • Sheridan, D.1    Carter, C.2    Kelton, J.G.3
  • 21
    • 0028243705 scopus 로고
    • Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complexes of heparin and platelet factor 4
    • Kelton J.G., Smith J.W., Warkentin T.E., Hayward C.P.M., Denomme G.A., Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complexes of heparin and platelet factor 4. Blood. 83:1994;3232-3239.
    • (1994) Blood , vol.83 , pp. 3232-3239
    • Kelton, J.G.1    Smith, J.W.2    Warkentin, T.E.3    Hayward, C.P.M.4    Denomme, G.A.5    Horsewood, P.6
  • 22
    • 0030703541 scopus 로고    scopus 로고
    • Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequeces on cross-reactivity with danapariod sodium
    • Poupard C., Amiral J., Borg J.Y., Vissac A.M., Delahousse B., Gruel Y. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequeces on cross-reactivity with danapariod sodium. Br. J. Haematol. 99:1997;273-280.
    • (1997) Br. J. Haematol. , vol.99 , pp. 273-280
    • Poupard, C.1    Amiral, J.2    Borg, J.Y.3    Vissac, A.M.4    Delahousse, B.5    Gruel, Y.6
  • 23
    • 0029878458 scopus 로고    scopus 로고
    • Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
    • Amiral J., Wolf M., Fischer A.M., Boyer-Neumann C., Vissac A.M., Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br. J. Haematol. 92:1996;954-959.
    • (1996) Br. J. Haematol. , vol.92 , pp. 954-959
    • Amiral, J.1    Wolf, M.2    Fischer, A.M.3    Boyer-Neumann, C.4    Vissac, A.M.5    Meyer, D.6
  • 24
    • 0035874509 scopus 로고    scopus 로고
    • Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia
    • Poulpard C., Iochmann S., Renard B., Herault O., Colombat P., Amerial J., Gruel Y. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood. 97:2001;3300-3302.
    • (2001) Blood , vol.97 , pp. 3300-3302
    • Poulpard, C.1    Iochmann, S.2    Renard, B.3    Herault, O.4    Colombat, P.5    Amerial, J.6    Gruel, Y.7
  • 25
    • 0027283778 scopus 로고
    • Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea pig, hamster and rat blood: Activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists
    • Cook N.S., Zerwes H.G., Tapparelli C., Powling M., Singh J., Mettemich R., Hagenback A. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb. Haemost. 70:1993;531-539.
    • (1993) Thromb. Haemost. , vol.70 , pp. 531-539
    • Cook, N.S.1    Zerwes, H.G.2    Tapparelli, C.3    Powling, M.4    Singh, J.5    Mettemich, R.6    Hagenback, A.7
  • 26
  • 27
    • 0032895104 scopus 로고    scopus 로고
    • Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT
    • Walenga J.M., Jeske W.P., Wallis D.E., Bakhos M., Lewis B.E., Leya F., Fareed J. Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT. Semin. Thromb. Hemost. 25(Suppl. 1):1999;77-81.
    • (1999) Semin. Thromb. Hemost. , vol.25 , Issue.SUPPL. 1 , pp. 77-81
    • Walenga, J.M.1    Jeske, W.P.2    Wallis, D.E.3    Bakhos, M.4    Lewis, B.E.5    Leya, F.6    Fareed, J.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.